These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20856245)

  • 1. Efficacy, safety, and ethics of cosmetic neurology far from settled.
    Flower K; Li L; Chen CY; Baggott MJ; Galloway GP; Mendelson J
    Clin Pharmacol Ther; 2010 Oct; 88(4):461-3. PubMed ID: 20856245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroenhancement: wisdom of the masses or "false phronesis"?
    Larriviere D; Williams MA
    Clin Pharmacol Ther; 2010 Oct; 88(4):459-61. PubMed ID: 20856244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American culture and neuro-cognitive enhancing drugs.
    Flaskerud JH
    Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164
    [No Abstract]   [Full Text] [Related]  

  • 4. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
    Boot BP; Partridge B; Hall W
    Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology.
    Cakic V
    J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterproductive criminal rehabilitation: Dealing with the double-edged sword of moral bioenhancement via cognitive enhancement.
    Shaw E
    Int J Law Psychiatry; 2019; 65():101378. PubMed ID: 30206004
    [No Abstract]   [Full Text] [Related]  

  • 7. Expectations regarding cognitive enhancement create substantial challenges.
    Racine E; Forlini C
    J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical issues in the use of cognitive enhancement.
    Darby R
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(2):16-22. PubMed ID: 20455376
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of methylphenidate among students: the future of enhancement?
    Outram SM
    J Med Ethics; 2010 Apr; 36(4):198-202. PubMed ID: 20338928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 11. Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety.
    Partridge B; Bell S; Lucke J; Hall W
    Drug Alcohol Rev; 2013 May; 32(3):295-302. PubMed ID: 23121045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood.
    Dees RH
    Neurology; 2005 Apr; 64(7):1320; author reply 1320. PubMed ID: 15832458
    [No Abstract]   [Full Text] [Related]  

  • 13. Just treat, or enhance?
    Kennedy D
    Science; 2004 Apr; 304(5667):17. PubMed ID: 15060288
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging cognitive enhancing drugs.
    Buccafusco JJ
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):577-89. PubMed ID: 19772371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Using ginseng root and other herbal adaptogens as nootropic drugs].
    Arushanian EB
    Eksp Klin Farmakol; 2008; 71(6):58-66. PubMed ID: 19140520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in children with Down syndrome: issues from a cognitive research perspective.
    Heller JH; Spiridigliozzi GA; Crissman BG; Sullivan-Saarela JA; Li JS; Kishnani PS
    Am J Med Genet C Semin Med Genet; 2006 Aug; 142C(3):187-95. PubMed ID: 16838317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain gain: the underground world of neuroenhancing drugs.
    Talbot M
    New Yorker; 2009 Apr; ():32-43. PubMed ID: 19399986
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroenhancing public health.
    Shaw D
    J Med Ethics; 2014 Jun; 40(6):389-91. PubMed ID: 23793059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.